Lawmakers seek the removal of Glavin

Share this article:
FDA associate commissioner for regulatory affairs Margaret O'K. Glavin should be removed from her post for sending a "retaliatory" all-hands memo to the agency's field employees shortly after congressional testimony by several dissident field managers gave the agency low grades for its food inspection performance, House Energy and Commerce leaders said in a letter to FDA commissioner Andrew von Eschenbach.

“(G)iven Ms. Glavin's blatant conduct, she should be removed from her position directing FDA field staff and replaced by someone who truly believes in reforming the way the FDA does business,” Oversight and Investigations Subcommittee chairman Bart Stupak (D-MI) was quoted in a news release as saying.

“At the same time, the commissioner needs to publicly repudiate and condemn her statements as contrary to the law and his policies at the FDA,” he continued.

Glavin's conduct could be a federal law violation, said full committee chairman John Dingell (D-MI). He added that her memo contradicted  previous testimony by von Eschenbach about not tolerating intimidation or retaliation of any kind.

Dingell is sponsoring a bill to prevent the FDA from proceeding with a plan by Glavin to close seven of the agency's 13 field laboratories and consolidate district offices, and to require any future closings to first gain congressional approval.

Share this article:

Email Newsletters

More in News

Meaningful use not linked to quality: study

Meaningful use not linked to quality: study

A recent study of physicians found no correlation between following EHR meaningful use requirements and providing consistently higher quality of care.

Lilly Q1 sales dip

Lilly Q1 sales dip

US sales fell 34% during the quarter, largely due to lower demand and lower prices for off-patent Cymbalta and Evista.

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...